tiprankstipranks
Trending News
More News >
Intensity Therapeutics, Inc. (INTS)
NASDAQ:INTS
US Market

Intensity Therapeutics, Inc. (INTS) Income Statement

Compare
242 Followers

Intensity Therapeutics, Inc. Income Statement

Last quarter (Q3 2025), Intensity Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Intensity Therapeutics, Inc.'s net income was $-2.67M. See Intensity Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -147.00K$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 16.59M$ 8.17M$ 7.55M$ 8.01M$ 6.22M
Depreciation and Amortization
$ 0.00$ 147.00K$ 0.00$ 0.00$ 0.00
EBITDA
$ -16.27M$ -10.09M$ -7.50M$ -7.88M$ -6.03M
Operating Income
$ -16.59M$ -8.32M$ -7.55M$ -8.01M$ -6.22M
Other Income/Expenses
$ 317.00K$ -2.22M$ -32.00K$ 118.58K$ 192.77K
Pretax Income
$ -16.27M$ -10.54M$ -7.58M$ -7.90M$ -6.03M
Net Income
$ -16.27M$ -10.54M$ -7.58M$ -7.90M$ -5.96M
Per Share Metrics
Basic EPS
$ -1.17$ -0.87$ -0.58$ -0.60$ -0.46
Diluted EPS
$ -1.17$ -0.87$ -0.58$ -0.60$ -0.46
Weighted Average Shares Outstanding
13.91M 13.71M 13.10M 13.10M 13.10M
Weighted Average Shares Outstanding (Diluted)
13.91M 13.71M 13.10M 13.10M 13.10M
Currency in USD

Intensity Therapeutics, Inc. Earnings and Revenue History